Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-15

Clinical Trial Update: The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating nasal carbon dioxide as-needed for symptomatic relief in seasonal allergic rhini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nasal carbon dioxide therapy (carbon dioxide)

Snippet

Sponsor: Capnia, Inc. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED